The Hospital Anxiety and Depression Scale (HADS): Translation and validation study of the Iranian version

被引：474

作者：

Ali Montazeri

Mariam Vahdaninia

Mandana Ebrahimi

Soghra Jarvandi

机构：

[1] Iranian Institute for Health Sciences Research,

[2] Iranian Centre for Breast Cancer (ICBC),undefined

来源：

Health and Quality of Life Outcomes | / 1卷 / 1期

关键词：

Breast Cancer Patient; Emotional Functioning; Global Quality; Depression Subscale; Early Stage Breast Cancer Patient;

D O I：

10.1186/1477-7525-1-14

中图分类号：

学科分类号：

摘要：

Background: The Hospital Anxiety and Depression Scale (HADS) is a widely used instrument to measure psychological morbidity in cancer patients. This study aimed to translate and test the reliability and validity of the Iranian version of the HADS. Methods: The English language version of the HADS was translated into Persian (Iranian language) and was used in this study. The questionnaire was administered to a consecutive sample of 167 breast cancer patients and statistical analysis was performed to test the reliability and validity of the HADS. Results: In general the Iranian version of the HADS was found to be acceptable to almost all patients (99%). Cronbach's alpha coefficient (to test reliability) has been found to be 0.78 for the HADS anxiety sub-scale and 0.86 for the HADS depression sub-scale. Validity as performed using known groups comparison analysis showed satisfactory results. Both anxiety and depression subscales discriminated well between sub-groups of patients differing in clinical status as defined by their disease stage. Conclusion: This preliminary validation study of the Iranian version of the HADS proved that it is an acceptable, a reliable and valid measure of psychological distress among cancer patients. © 2003 Montazeri et al; licensee BioMed Central Ltd.

引用

页数：5

共 17 条

[1]

Herrmann C., International experiences with the Hospital Anxiety and Depression Scale: A review of validation data and clinical results, J. Psychosom. Res., 42, pp. 17-41, (1997)

[2]

Bjelland I., Dahl A.A., Tangen Haug T., Neckelmann A., The validity of the Hospital Anxiety and Depression Scale: An updated literature review, J. Psychosom. Res., 52, pp. 69-77, (2002)

[3]

Montazeri A., Harirchi I., Vahdani M., Anxiety and depression in Iranian breast cancer patients before and after diagnosis, Eur. J. Cancer Care, 9, pp. 151-157, (2000)

[4]

Nunnally J.C., Bernstien I.H., Psychometric Theory, (1994)

[5]

Montazeri A., Harirchi I., Vahdani M., The European Organization for Research and Treatment of Cancer: Translation and validation study of the Iranian version, Support Care Cancer, 7, pp. 400-406, (1999)

[6]

Zigmond A.S., Snaith P.R., The Hospital Anxiety and Depression Scale, Acta Psychiatr. Scand., 67, pp. 361-370, (1983)

[7]

Fayers P., Aaronson N., Bjordal K., Groenvold M., Curran D., Bottomley A., The EORTC QLQ-C30 Scoring Manual, (2001)

[8]

Lyons R.A., Wareham K., Lucas M., SF-36 scores vary by method of administration: Implication for study design, J. Publ. Hlth. Med., 21, pp. 41-45, (1999)

[9]

Costantini M., Musso M., Viterbori P., Detecting psychological distress in cancer patients: Validity of the Italian version of the Hospital Anxiety and Depression Scale, Support Care Cancer, 7, pp. 121-127, (1999)

[10]

Mykletun A., Stordal E., Dahl A.A., Hospital Anxiety and Depression (HAD) scale: Factor structure, item analyses and internal consistency in a large population, Br. J. Psychiatr., 179, pp. 540-544, (2001)

← 1 2 →